|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07C 235/34 | |
| A61K 31/165 | |||
| A61P 9/12 | |||
| A61P 13/12 |
| (11) | Patento numeris | 3046901 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14845373.1 |
| Europos patento paraiškos padavimo data | 2014-09-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-07-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-10-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/AU2014/000923 |
| Data | 2014-09-17 |
| (87) | Numeris | WO 2015/039173 |
| Data | 2015-03-26 |
| (30) | Numeris | Data | Šalis |
| 2013903573 | 2013-09-17 | AU |
| (72) |
DUGGAN, Karen Annette, AU
|
| (73) |
Vectus Biosystems Limited,
3-11 Primrose Avenue, Rosebery, NSW 2018,
AU
|
| (54) | COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION AND/OR FIBROSIS |
| COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION AND/OR FIBROSIS |